Key Takeaways
- Tesla’s Q2 financial results will be unveiled after trading concludes on July 22, with analysts projecting EPS between $0.52ā$0.54 and approximately $26.4B in revenue
- Despite exceeding Q2 delivery projections with 480,126 vehicles, TSLA shares have declined more than 15% since January
- Analyst consensus leans toward Hold with a mean price target of $405.42, suggesting 6.5% potential gains
- Key discussion points include robotaxi deployment timeline, Optimus humanoid robot developments, and capital expenditure rationale
- Derivatives traders anticipate approximately 7% price volatility following the earnings announcement
Tesla’s upcoming Q2 earnings announcement on July 22 after market hours carries significant weight for investors. With shares trailing the broader market by more than 15% this year, stakeholders are seeking concrete answers about the company’s strategic direction beyond its core automotive business.
Financial analysts are forecasting adjusted earnings per share ranging from $0.52 to $0.54, alongside revenue estimates hovering near $26.4 billion ā representing approximately 16% growth compared to the same period last year. The electric vehicle manufacturer previously announced Q2 deliveries totaling 480,126 vehicles with production reaching 451,758 units. Despite surpassing delivery expectations, the stock has shown minimal positive reaction.
Automotive gross margin stands as a critical metric for this quarter. Consensus estimates place it slightly above 18% when regulatory credits are excluded. Wells Fargo analyst Colin Langan projects a more conservative 16.8% ā falling short of both consensus and Q1’s 19.2% margin. His projection accounts for reduced vehicle pricing and the lack of one-time benefits that boosted earlier quarters.
Langan represents the more pessimistic camp among Wall Street analysts, holding a Sell rating alongside a $130 price objective. His concerns center on softening EV demand, ambiguity surrounding upcoming model introductions, and regulatory headwinds affecting autonomous vehicle technology.
Autonomous Vehicles and Humanoid Robots Take Center Stage
UBS analyst Joseph Spak adopts a more optimistic stance. While maintaining his Hold recommendation, he elevated his price target to $442, highlighting Tesla’s potential to exceed Q2 EPS projections by up to 37%. He also identifies an increasing probability that full-year 2026 vehicle deliveries could show positive year-over-year growth ā potentially triggering upward estimate revisions across the analyst community.
Morgan Stanley’s Andrew Percoco maintained his Hold assessment while increasing his target to $417. He anticipates strong performance in both automotive and energy segment deliveries, though he emphasizes that the critical question centers on whether Tesla’s rapidly expanding AI infrastructure investments justify their costs. Capital expenditures are more than doubling while free cash flow shifts negative, prompting investors to demand proof that this spending creates sustainable competitive positioning.
Bank of America analyst Alexander Perry is closely monitoring the robotaxi expansion. Tesla currently operates across five markets following the Miami launch on July 3, with four additional markets under development. Safety metrics through mid-June document 22 incidents since program inception, with zero serious injuries or deaths ā data that Perry suggests is gradually reducing skepticism surrounding Tesla’s camera-only autonomous approach.
Beyond the Financial Metrics
Optimus represents another significant variable. Tesla aims to begin initial humanoid robot manufacturing at its Fremont production facility during late July or August, potentially unveiling a Gen 3 version simultaneously. Supply chain intelligence suggests production capacity of roughly 1,000 units weekly by September, scaling toward 2,000ā2,500 units weekly before year-end.
Morgan Stanley anticipates Elon Musk will provide detailed commentary on Optimus production scaling, final design specifications, and initial deployment scenarios during the earnings call.
Current Wall Street consensus reflects 16 Hold ratings, 10 Buy recommendations, and 3 Sell ratings. The mean price target of $405.42 indicates potential upside of 6.5% from present trading levels. Options market pricing suggests a 7% price movement in either direction following the earnings release.


